It has been nearly four months since my previous coverage of Ethan Allen Interiors Inc. ( ETD ). From my cautious stance before, I was a bit too early to shift to an optimistic approach. The stockI have been working in the logistics sector for almost two decades. I have been into stock investing and macroeconomic analysis for almost a decade. Currently, I focus on ASEAN and NYSE/NASDAQ Stocks, particularly in banks, telco, logistics, and hotels. Since 2014, I have been trading on the PH stock market. I focu ...

It has been nearly four months since my previous coverage of Ethan Allen Interiors Inc. ( ETD ). From my cautious stance before, I was a bit too early to shift to an optimistic approach. The stockI have been working in the logistics sector for almost two decades. I have been into stock investing and macroeconomic analysis for almost a decade. Currently, I focus on ASEAN and NYSE/NASDAQ Stocks, particularly in banks, telco, logistics, and hotels. Since 2014, I have been trading on the PH stock market. I focu ...

The Bitcoin rout continues, one IPO pauses while three more move ahead, Hims & Hers offers knockoff Wegovy pill, and more news to start your day. ...

Core Viewpoint - The technology sector has experienced significant declines, but the S&P 500 remains only 2.6% below its record high, indicating potential for recovery in the tech sector [1]. Group 1: Market Performance - The S&P 500 has only decreased by 2.6% from its all-time high despite the turmoil in the technology sector [1]. - The recent market dip has been accompanied by high volatility in precious metals and a collapse in cryptocurrency markets [1]. Group 2: Sector Analysis - A popular software ETF is currently at extremely oversold levels, suggesting a potential bounce back for the technology sector [1]. - Concerns about artificial intelligence impacting software and large capital expenditure commitments have contributed to the downturn in tech stocks [1].

Core Viewpoint - Canada Nickel Company has secured a US$32 million bridge loan facility from Auramet International to advance its Crawford Nickel Sulphide Project and repay an existing loan with BT Capital [1][2]. Loan Facility - The bridge loan will close on or before February 9, 2026, and is due on May 9, 2026, with an interest rate of 1.00% per month and a 2.5% arrangement fee [2]. - Auramet will receive 1,750,000 one-year warrants at a 5% premium to the 5-day volume weighted average price of the company's shares prior to the closing date [2]. - Proceeds from the loan will be used for working capital and to repay the existing loan with BT Capital, subject to customary conditions including TSX Venture Exchange approval [2]. About Auramet - Auramet is a private company established in 2004, specializing in physical precious metals trading and project finance advisory services, with over $1.3 billion in term financing provided to date [3]. About Canada Nickel Company - Canada Nickel is focused on advancing nickel-sulphide projects to meet the demand from the electric vehicle and stainless-steel markets [4]. - The company is developing processes for net zero carbon nickel, cobalt, and iron products and is anchored by its Crawford Nickel-Cobalt Sulphide Project in the Timmins-Cochrane mining camp [4].

Core Viewpoint - Pfizer Inc. has received Priority Review from the U.S. FDA for its supplemental Biologics License Application for HYMPAVZI® (marstacimab), aiming to expand its indication for treating hemophilia A or B patients aged 6 years and older with inhibitors, as well as pediatric patients aged 6 to 11 with hemophilia A or B without inhibitors [1] Group 1 - The FDA has accepted Pfizer's supplemental Biologics License Application for HYMPAVZI® [1] - The application seeks to expand the treatment indication to include hemophilia A or B patients aged 6 years and older with inhibitors [1] - The application also targets pediatric patients aged 6 to 11 with hemophilia A or B without inhibitors [1]

Core Insights - MIAX Exchange Group reported a 25.1% year-over-year increase in average daily trading volume (ADV) for multi-list options, reaching 11.1 million contracts in January 2026 [1][6] - The market share for MIAX Exchange Group options increased to 17.6%, marking a 5.5% rise year-over-year [6] Trading Volume and Market Share - U.S. Equity Options Industry ADV was 63,025 thousand contracts, an 18.6% increase from January 2025 [3] - MIAX Exchange Group Options ADV was 11,100 thousand contracts, a 25.1% increase compared to January 2025 [3][6] - MIAX Futures ADV reached 7,359 contracts, reflecting a 51.9% increase from December 2025 [6] Performance Comparison - MIAX Pearl ADV decreased by 17.3% year-over-year, totaling 161 million [3] - MIAX Pearl Market Share fell to 0.8%, a decline of 34.3% compared to the previous year [3] - The U.S. Equities Industry ADV was 19,436 million, a 25.9% increase from January 2025 [3]

Core Viewpoint - Hims & Hers faces legal action from Novo Nordisk after announcing plans to launch a cheaper version of Novo's weight loss pill, leading to significant stock price fluctuations [1][2] Group 1: Stock Performance - Hims & Hers stock initially spiked by 15% following the announcement but ended the trading session down 3.8%, reaching a 12-month low [1] - In premarket trading on Friday, shares fell an additional 6.7% after Novo Nordisk labeled the action as "illegal" [1] Group 2: Product Launch Details - Hims plans to introduce a Wegovy-style pill containing semaglutide, priced at $49 for the first month with a subscription, increasing to $99 thereafter [2] - This pricing is significantly lower than Novo Nordisk's starting dose price of $149 on its NovoCare website [2]

Core Viewpoint - Atmus Filtration Technologies Inc. has appointed Heath Sharp to its Board of Directors, highlighting his extensive experience in scaling industrial businesses internationally [1] Company Summary - Atmus Filtration Technologies Inc. is recognized as a global leader in the filtration industry [1] - The CEO and President of Atmus, Steph Disher, emphasized Sharp's over 30 years of leadership experience in manufacturing, product development, and commercial execution [1] Leadership Impact - Heath Sharp's appointment is expected to enhance Atmus's strategic direction and operational execution due to his seasoned background in the industrial sector [1]

Core Insights - Apple Inc. is scaling back its plans for an AI-based health coach, indicating challenges in monetizing health tracking services [1][2] - The initiative, known internally as Health+, will not be launched as a standalone service but will integrate features into the existing Health app over time [2][4] Group 1: Leadership and Strategy Changes - A leadership change occurred in Apple's health organization, with Eddy Cue taking over after Jeff Williams' retirement, emphasizing the need for faster progress [3] - Cue has identified competitors like Oura and Whoop as offering more appealing features, prompting a reevaluation of Apple's health offerings [3] Group 2: Product Development and Features - The AI health coach was delayed multiple times, initially planned for iOS 26 and later for iOS 27, which is set for September [4] - The service aimed to provide health reports and AI-driven recommendations using data from Apple Watch and external lab reports, with some video content repurposed for the Health app [4] Group 3: Competitive Landscape - Competition in health tracking is intensifying, with Samsung gaining ground and OpenAI launching "ChatGPT Health" for data analysis and feedback [5] - Apple is also developing an AI chatbot for health inquiries and plans for Siri to handle more advanced health questions in the future [5]